Vyome Therapeutics, a clinical-stage specialty pharmaceutical company developing novel medicines for...View More
Vyome Therapeutics announced that it has dosed the first patient in its Phase 2 trial of the Company...View More
Vyome Therapeutics has built platforms and is developing products that address antibiotic resistance...View More
Vyome Therapeutics Inc CEO Venkat Nelabhotla sat down with Proactive Investors at the BIO CEO & Inve...View More
Vyome Therapeutics Inc. has announced a $22 million financing for the phase IIb trial of its lead mo...View More
Vyome Therapeutics' lead product, which targets the drug-resistant acne market, received approval of...View More
Proceeds to finance phase 2b clinical trial for a drug with novel mechanism of action against modera...View More
Copyright © 2015 Vyome Therapeutics Inc. All rights reserved.